Record on Satisfaction of Patients With Actonel [risedronic acid] 35 mg Once a Week.
Phase of Trial: Phase IV
Latest Information Update: 12 Mar 2010
At a glance
- Drugs Risedronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms ROSPA
- Sponsors Sanofi
- 03 Jul 2009 Planned end date added as 1 Sep 2006 as reported by ClinicalTrials.gov.
- 03 Jul 2009 Actual patient number (7) added as reported by ClinicalTrials.gov.
- 02 Nov 2007 New trial record.